DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo


11.26 -0.52 (-4.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ZIOP $11.26 -4.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.45
Previous Close $11.78
Daily Range $11.10 - $12.02
52-Week Range $2.31 - $12.02
Market Cap $1.2B
P/E Ratio -38.00
Dividend (Yield) $0.00 (0.0%)
Volume 6,275,538
Average Daily Volume 5,615,969
Current FY EPS -$0.40




Drug Makers

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website:

News & Commentary Rss Feed

This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed

Intrexon, led by biotech billionaire R.J. Kirk, acquired a little known Belgian biotech. Is it a big deal for investors?

Intrexon: Back-End Economics Could Generate Huge Upside

Friday's #PreMarket Movers: JC Penney Down Following Q4 Earnings

Fireye, 3 More Are Hot Momentum Stocks Despite Overheated Market

Bullish Traders Take Another Dose of Ziopharm Oncology

Fast Money Halftime Report Final Trade From February 23

New Lifetime High For ZIOPHARM Oncology (ZIOP) Daily Round Up 2/10/15: ZIOP, WMS, R, MLNK

Why Intrexon Corp's Shares are Up 14% Today

Intrexon shares rocketed higher. Here's what you need to know.

Health Care Sector Update for 02/04/2015: ZIOP, CTRV, PACB, CMRX

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $11.26 (-4.41%)
Current stock: ZIOP
AMGN $157.72 (-0.79%)
Current stock: AMGN
GILD $103.53 (-0.63%)
Current stock: GILD
BIIB $409.59 (-0.12%)
Current stock: BIIB